Patent directory · USPTO A61K / A61P
Patents matching “Takeda Pharmaceutical Company Limited”
1,022 pharma patents match "Takeda Pharmaceutical Company Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,022 pharmaceutical patents matching "Takeda Pharmaceutical Company Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12202797
Method for producing pyrrole compound
granted -
US 12202901
Cannabinoid receptor type 1 (CB1) antibodies, encoding nucleic acid molecules thereof and methods of use thereof
granted -
US 12202832
Heterocyclic compounds having a calcium-sensing receptor antagonistic activity
granted -
US 12186313
Pyridazinone compounds and their use as DAAO inhibitors
granted -
US 12188948
Metabolite biomarkers for diseases associated with the contact activation system
granted -
US 12178981
Drug administration method
granted -
US 12178861
Stabilized liquid and lyophilized ADAMTS13 formulations
granted -
US 12171832
Methods of treating ulcerative colitis
granted -
US 12171777
Methods of making a cyclic dinucleotide
granted -
US 12168041
Methods and compositions for CNS delivery of arylsulfatase A
granted -
US 12161702
Methods and compositions for CNS delivery of heparan N-sulfatase
granted -
US 12162864
Condensed-cyclic compound
granted -
US 12156903
Use of ADAMTS13 for treating, ameliorating and/or preventing vaso-occlusive crisis in sickle cell disease, acute lung injury and/or acute respiratory distress syndrome
granted -
US 12152027
Heterocyclic compound
granted -
US 12144809
Treatment of prostate cancer
granted -
US 12128090
Methods of prophylactic treatment using recombinant VWF (rVWF)
granted -
US 12128102
Constrained conditionally activated binding proteins
granted -
US 12122815
GIP receptor agonist peptide compounds and uses thereof
granted -
US 12121569
Methods and compositions for CNS delivery of iduronate-2-sulfatase
granted -
US 12110343
Anti-plasma kallikrein antibodies
granted -
US 12097199
Administration of SUMO-activating enzyme inhibitor and anti-CD20 antibodies
granted -
US 12097306
Conformal coating of biological surfaces
granted -
US 12097198
Treatment of prostate cancer
granted -
US 12091410
Heterocyclic compound
granted